Inhibition of XPO1 impairs cholangiocarcinoma cell proliferation by triggering p53 intranuclear accumulation
出版年份 2022 全文链接
标题
Inhibition of XPO1 impairs cholangiocarcinoma cell proliferation by triggering p53 intranuclear accumulation
作者
关键词
-
出版物
Cancer Medicine
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2022-10-06
DOI
10.1002/cam4.5322
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Dual Inhibition of mTORC1/2 Reduces Migration of Cholangiocarcinoma Cells by Regulation of Matrixmetalloproteinases
- (2022) Katharina Joechle et al. Frontiers in Cell and Developmental Biology
- Selinexor improves the anti-cancer effect of tucidinostat on TP53 wild-type breast cancer
- (2022) Yingfang Shi et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Combining selinexor with alisertib to target the p53 pathway in neuroblastoma
- (2022) Rosa Nguyen et al. NEOPLASIA
- UBAP2L promotes gastric cancer metastasis by activating NF-κB through PI3K/AKT pathway
- (2022) Ou Li et al. Cell Death Discovery
- XPO1 inhibition synergizes with PARP1 inhibition in small cell lung cancer by targeting nuclear transport of FOXO3a
- (2021) Jingya Wang et al. CANCER LETTERS
- XPO1/CRM1 is a promising prognostic indicator for neuroblastoma and represented a therapeutic target by selective inhibitor verdinexor
- (2021) Lijia Pan et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- PSEN1-selective gamma-secretase inhibition in combination with kinase or XPO-1 inhibitors effectively targets T cell acute lymphoblastic leukemia
- (2021) Inge Govaerts et al. Journal of Hematology & Oncology
- The miR-34a/WNT7B modulates the sensitivity of cholangiocarcinoma cells to p53-mediated photodynamic therapy toxicity
- (2021) Yuanshan Han et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Verdinexor, a Selective Inhibitor of Nuclear Exportin 1, Inhibits the Proliferation and Migration of Esophageal Cancer via XPO1/c-Myc/FOSL1 Axis
- (2021) Ling Ou et al. International Journal of Biological Sciences
- Chromosome Region Maintenance 1 (XPO1/CRM1) as an Anticancer Target and Discovery of Its Inhibitor
- (2021) Song Liu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Selinexor Enhances NK Cell Activation Against Malignant B Cells via Downregulation of HLA-E
- (2021) Jack G. Fisher et al. Frontiers in Oncology
- XPO1 Expression Is a Poor-Prognosis Marker in Pancreatic Adenocarcinoma
- (2019) Birnbaum et al. Journal of Clinical Medicine
- Structural prerequisites for CRM1-dependent nuclear export signaling peptides: accessibility, adapting conformation, and the stability at the binding site
- (2019) Yoonji Lee et al. Scientific Reports
- Targeting Nuclear Exporter Protein XPO1/CRM1 in Gastric Cancer
- (2019) Rachel Sexton et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The LINC01714 enhances Gemcitabine sensitivity by modulating FOXO3 phosphorylation in cholangiocarcinoma
- (2019) Sheng Shen et al. Molecular Therapy-Nucleic Acids
- Expression, function, and targeting of the nuclear exporter chromosome region maintenance 1 (CRM1) protein
- (2015) Jo Ishizawa et al. PHARMACOLOGY & THERAPEUTICS
- Structural determinants of nuclear export signal orientation in binding to exportin CRM1
- (2015) Ho Yee Joyce Fung et al. eLife
- BIRC6 promotes hepatocellular carcinogenesis: Interaction of BIRC6 with p53 facilitating p53 degradation
- (2014) Wenqing Tang et al. INTERNATIONAL JOURNAL OF CANCER
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started